Clinical Trial Update: Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin, gemcitabine, and bevacizumab in women with recurrent Mullerian carcinomas; the study (NCT00418093) was terminated but resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-06-19